Selective preoperative magnetic resonance imaging in women with breast cancer: No reduction in the reoperation rate

Archives of Surgery

Volumn 147, Issue 9, 2012, Pages 834-839

  Weber, Joseph J ^a   Bellin, Lisa S ^a   Milbourn, David E ^a   Verbanac, Kathryn M ^a,b   Wong, Jan H ^a,b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER SURGERY; FEMALE; HISPANIC; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SURGEON; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREOPERATIVE CARE; REOPERATION; RETROSPECTIVE STUDIES;

EID: 84866502694     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2012.1660     Document Type: Article

References (35)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-1241.
2. Lehman CD, DeMartini W, Anderson BO, Edge SB. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw. 2009;7(2):193-201.
3. Lehman CD, Gatsonis C, Kuhl CK, et al; ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356(13):1295-1303.
4. ACR practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. Revised 2008. http://www-test.acr.org/ SecondaryMainMenuCategories/quality-safety/guidelines/breast/mri-breast.aspx. Accessed June 9, 2012.
5. American Society of Breast Surgeons. Position statement on the use magnetic resonance imaging in breast surgical oncology. 2010. http://www.breastsurgeons.org/statements/PDF-Statements/MRI.pdf. Accessed June 9, 2012.
6. Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology. 2006;239(2):385-391.
7. Hall FM. Mammographic density categories. AJR Am J Roentgenol. 2002;178(1):242-243.
8. Fisher B, Anderson S; National Surgical Adjuvant Breast and Bowel Project. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. World J Surg. 1994;18(1):63-69.
9. Turnbull L, Brown S, Harvey I, et al. Comparative Effectiveness of MRI in Breast Cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375(9714): 563-571.
10. Millet I, Pages E, Hoa D, et al. Pearls and pitfalls in breast MRI. Br J Radiol. 2012;85(1011):197-207.
11. Department of Health and Human Services. North Carolina State Center for Health Statistics. http://www.schs.state.nc.us/SCHS/. Accessed June 9, 2012.
12. Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59(5):290-302.
13. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and metaanalysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248-3258.
14. MorrowM.Magnetic resonance imaging in breast cancer: one step forward, two steps back? JAMA. 2004;292(22):2779-2780.
15. Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007;142(5):441-447.
16. Godinez J, Gombos EC, Chikarmane SA, Griffin GK, Birdwell RL. Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation. AJR Am J Roentgenol. 2008;191(1):272-277.
17. Bagley FH. The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer. Arch Surg. 2004;139(4):380-383.
18. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98(3):468-473.
19. Lagios MD. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer. 1977;40(4):1726-1734.
20. Sardanelli F, Giuseppetti GM, Panizza P, et al; Italian Trial for BreastMRin Multifocal/Multicentric Cancer. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183(4):1149-1157.
21. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-1232.
22. Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma: imaging features and clinical detection. Invest Radiol. 1993;28(3):202-207.
23. Bassett L, Lee J, Hsu C. Breast imaging. In: Bland K, Copeland E III, eds. The Breast: Comprehensive Management of Benign and Malignant Diseases. 4th ed. Philadelphia, PA: Elsevier; 2009.
24. Hilleren DJ, Andersson IT, Lindholm K, Linnell FS. Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology. 1991;178(1):149-154.
25. Sickles EA. The subtle and atypical mammographic features of invasive lobular carcinoma. Radiology. 1991;178(1):25-26.
26. Yeatman TJ, Cantor AB, Smith TJ, et al. Tumor biology of infiltrating lobular carcinoma: implications for management. Ann Surg. 1995;222(4):549-561.
27. Kneeshaw PJ, Turnbull LW, Smith A, Drew PJ. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol. 2003;29(1):32-37.
28. Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics. 2009;29(1):165-176.
29. Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat. 2008;107(1):1-14.
30. Pengel KE, Loo CE, Teertstra HJ, et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat. 2009;116(1):161-169.
31. Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209(2):180-187, 294-295.
32. Wolberg WH, Tanner MA, Romsaas EP, Trump DL, Malec JF. Factors influencing options in primary breast cancer treatment. J Clin Oncol. 1987;5(1):68-74.
33. Celaya MO, Rees JR, Gibson JJ, Riddle BL, Greenberg ER. Travel distance and season of diagnosis affect treatment choices for women with early-stage breast cancer in a predominantly rural population (United States). Cancer Causes Control. 2006;17(6):851-856.
34. McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307(5):467-475.
35. Le-Petross H, Lane D. Challenges and potential pitfalls in magnetic resonance imaging of more elusive breast carcinomas. Semin Ultrasound CT MR. 2011;32(4):342-350.